Cargando…
Immune checkpoint inhibitors and their interaction with proton pump inhibitors–related interstitial nephritis
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy and outcomes, leading to an expanding use in millions of patients worldwide. However, they can cause a spectrum of immune-related adverse events (irAEs). Essentially, any organs can be affected by irAEs, which have emerged as the...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616479/ https://www.ncbi.nlm.nih.gov/pubmed/37915905 http://dx.doi.org/10.1093/ckj/sfad109 |